Cytokinetics reported $807K in Stock for its fiscal quarter ending in September of 2026.





Stock Change Date
Acadia Pharmaceuticals USD 40.36M 68.31M Sep/2026
Amgen USD 6.39B 169M Sep/2026
Bayer EUR 11.97B 43M Jun/2026
Biogen USD 2.22B 159.9M Sep/2026
Bristol-Myers Squibb USD 2.7B 33M Sep/2026
Cytokinetics USD 807K 427K Sep/2026
Eisai JPY 272.61B 15.06B Sep/2026
Eli Lilly USD 18.19B 1.4B Sep/2026
Exelixis USD 29.87M 1.14M Sep/2026
Geron USD 126.6M 3M Sep/2026
Halozyme Therapeutics USD 132.61M 4.52M Sep/2026
Ionis Pharmaceuticals USD 28.58M 22.26M Sep/2026
Ligand Pharmaceuticals USD 14.51M 4.24M Sep/2026
Merck USD 6.16B 43M Sep/2026
Novartis USD 6.1B 116M Sep/2026
Pfizer USD 10.02B 77M Sep/2026
Regeneron Pharmaceuticals USD 2.89B 189.7M Sep/2026
Roche Holding CHF 7.6B 9M Jun/2025
Sanofi EUR 24.12B 620M Jun/2026